Option

Liberty Expands to the Boston Area to Accelerate Company Growth

Thursday, July 29, 2021 - 1:00pm

The new office is located in Wilmington, Massachusetts, a short distance from Boston, and will serve as Liberty Defense's headquarters effective September 2021.

Key Points: 
  • The new office is located in Wilmington, Massachusetts, a short distance from Boston, and will serve as Liberty Defense's headquarters effective September 2021.
  • The Boston-area office will include space dedicated to product development of new and emerging technologies that the Company is developing.
  • "This coming year will be a pivotal time for Liberty, as we have begun ramping up to support HEXWAVE beta deployment and future commercial growth.
  • We needed this additional space to expand and diversify our product development portfolio," said Liberty Defense CEO Bill Frain.

Logiq Announces Exercise of Over-Allotment Option in Initial Public Offering

Tuesday, July 27, 2021 - 2:55pm

The total gross proceeds to the Company from the Offering, including the 1,976,434 Units sold initially and the partial exercise of the over-allotment option, is approximately C$6,534,402.

Key Points: 
  • The total gross proceeds to the Company from the Offering, including the 1,976,434 Units sold initially and the partial exercise of the over-allotment option, is approximately C$6,534,402.
  • The net proceeds of the Offering will be used for development of additional data analytics tools, sales generation and marketing, and for working capital requirements and other general corporate purposes.
  • Logiq Inc. is a U.S.-based leading global provider of e-commerce and fintech business enablement solutions.
  • Any forwardlooking statements contained in this press release are expressly qualified in their entirety by this cautionary statement.

Saint Jean Carbon Announces Option Grants

Monday, July 26, 2021 - 1:53pm

CALGARY, Alberta, July 26, 2021 (GLOBE NEWSWIRE) -- Saint Jean Carbon Inc. (Saint Jean or the Company) (TSX-V: SJL) announces that it has granted an aggregate of 2,350,000 options (the Options), of which 1,600,000 Options have been granted to a current Director of the Company, pursuant to the Companys stock option plan.

Key Points: 
  • CALGARY, Alberta, July 26, 2021 (GLOBE NEWSWIRE) -- Saint Jean Carbon Inc. (Saint Jean or the Company) (TSX-V: SJL) announces that it has granted an aggregate of 2,350,000 options (the Options), of which 1,600,000 Options have been granted to a current Director of the Company, pursuant to the Companys stock option plan.
  • FORWARD LOOKING STATEMENTS: This press release contains forward-looking statements, within the meaning of applicable securities legislation, concerning Saint Jeans business and affairs.
  • A number of factors, including those discussed above, could cause actual results to differ materially from the results discussed in the forward-looking statements.
  • Forward-looking information is provided as of the date of this press release, and Saint Jean assumes no obligation to update or revise them to reflect new events or circumstances, except as may be required under applicable securities legislation.

Easterly Government Properties Acquires 61,384 SF Multi-Tenanted Facility in Cleveland, OH

Monday, July 26, 2021 - 2:00pm

The National Weather Service (NWS) occupies 15% of the building under an initial 20-year term that does not expire until September 2040.

Key Points: 
  • The National Weather Service (NWS) occupies 15% of the building under an initial 20-year term that does not expire until September 2040.
  • In total, and assuming the VNA exercises its renewal options, the facility is 100% occupied with a weighted average lease expiration of June 2034.
  • Pro forma for this acquisition, Easterly has 85 properties totaling 7.7 million square feet.
  • Easterly Government Properties, Inc. (NYSE:DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government.

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thursday, July 22, 2021 - 9:05pm

The inducement stock options and RSUs have a grant date and vesting commencement date of July 16, 2021 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The inducement stock options and RSUs have a grant date and vesting commencement date of July 16, 2021 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The inducement stock options and inducement RSUs are subject to the terms and conditions of Arena's Amended and Restated 2021 Long-Term Incentive Plan.
  • ARENA Pharmaceuticals is a team with a singular purpose deliver important medicines to patients.
  • Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

C-COM Announces Issuance of Stock Options

Thursday, July 22, 2021 - 1:00pm

The stock options were granted pursuant to the terms of C-COM's stock option plan and are exercisable at $2.90 per share.

Key Points: 
  • The stock options were granted pursuant to the terms of C-COM's stock option plan and are exercisable at $2.90 per share.
  • Stock option grants are subject to necessary regulatory approvals.
  • About C-COM Satellite Systems Inc.
    C-COM Satellite Systems Inc. is a pioneer and world leader in the design, development, and manufacture of transportable and mobile satellite-based antenna systems.
  • The Company is publicly traded on the Canadian Venture Exchange (TSXV: CMI) and on the US OTC Exchange (OTCQB: CYSNF).

Passage Bio Announces Inducement Award for Newly Appointed Chief Commercial Officer Under Nasdaq Listing Rule 5635(c)(4)

Wednesday, July 21, 2021 - 12:00pm

PHILADELPHIA, July 21, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced it has granted an inducement award to the companys newly appointed Chief Commercial Officer, M. Maria Trnsn, under an inducement plan adopted by its board of directors.

Key Points: 
  • PHILADELPHIA, July 21, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced it has granted an inducement award to the companys newly appointed Chief Commercial Officer, M. Maria Trnsn, under an inducement plan adopted by its board of directors.
  • Passage Bio granted an option to purchase 200,000 shares of common stock and 20,000 restricted stock units (RSUs) to Ms. Trnsn as a material inducement to her employment in accordance with the Nasdaq listing Rule 5635(c)(4).
  • The stock options have an exercise price of $13.04 per share, which is equal to the closing price of Passage Bios common stock on the grant date.
  • The stock options have a 10-year term and are subject to the terms and conditions of the stock option agreement.

Toews Agility Shares™ Managed Risk ETF Listed As One Of Morningstar’s Top-Ranked Options Trading ETFs Over 1-Year Annualized Return

Wednesday, July 21, 2021 - 2:30pm

Toews Agility Shares provides risk-managed strategies within actively managed exchange-traded funds for investors.

Key Points: 
  • Toews Agility Shares provides risk-managed strategies within actively managed exchange-traded funds for investors.
  • Toews Agility Shares is powered by Toews research, innovation and expertise in working with investors since 1994.
  • The Toews Funds Agility Shares Managed Risk ETF is distributed by Northern Lights Distributors LLC, member FINRA/SIPC.
  • US Fund Options Trading strategies use a variety of options trades, including put writing, options spreads, options-based hedged equity, and collar strategies, among others.

HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering

Monday, July 19, 2021 - 11:39pm

The shares are expected to begin trading on the Nasdaq Global Market on July 20, 2021, under the ticker symbol HCWB.

Key Points: 
  • The shares are expected to begin trading on the Nasdaq Global Market on July 20, 2021, under the ticker symbol HCWB.
  • The offering is expected to close on or about July 22, 2021, subject to satisfaction of customary closing conditions.
  • In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 1,050,000 shares at the public offering price less the underwriting discounts and commissions.
  • EF Hutton, division of Benchmark Investments, LLC, is acting as sole book-running manager for the offering.

ESE Announces Closing of $8.6 Million Bought Deal Public Offering

Monday, July 19, 2021 - 4:42pm

VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- ESE Entertainment Inc. (TSX-V: ESE) (OTCQB: ENTEF) ("ESE" or the "Company") is pleased to announce that it has closed its previously announced bought deal public offering for gross proceeds of $8,629,600, which includes the full exercise of the Over-Allotment Option (the Offering).

Key Points: 
  • VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- ESE Entertainment Inc. (TSX-V: ESE) (OTCQB: ENTEF) ("ESE" or the "Company") is pleased to announce that it has closed its previously announced bought deal public offering for gross proceeds of $8,629,600, which includes the full exercise of the Over-Allotment Option (the Offering).
  • Under the Offering, the Company sold 6,164,000 units of the Company (the Units) at a price of $1.40 per Unit (the Issue Price).
  • The Underwriters exercised the Over-Allotment Option in full, resulting in additional gross proceeds of $1,125,600 to the Company.
  • The net proceeds of the Offering will be used for business development, general working capital, and other general corporate purposes.